201 related articles for article (PubMed ID: 27487480)
1. In vitro and in vivo effects of morin on the intestinal absorption and pharmacokinetics of olmesartan medoxomil solid dispersions.
Surampalli G; Satla M; Nanjwade BK; Patil PA
Drug Dev Ind Pharm; 2017 May; 43(5):812-829. PubMed ID: 27487480
[TBL] [Abstract][Full Text] [Related]
2. Corroboration of naringin effects on the intestinal absorption and pharmacokinetic behavior of candesartan cilexetil solid dispersions using in-situ rat models.
Surampalli G; K Nanjwade B; Patil PA
Drug Dev Ind Pharm; 2015; 41(7):1057-65. PubMed ID: 24918161
[TBL] [Abstract][Full Text] [Related]
3. In situ intestinal permeability and in vivo absorption characteristics of olmesartan medoxomil in self-microemulsifying drug delivery system.
Kang MJ; Kim HS; Jeon HS; Park JH; Lee BS; Ahn BK; Moon KY; Choi YW
Drug Dev Ind Pharm; 2012 May; 38(5):587-96. PubMed ID: 21988221
[TBL] [Abstract][Full Text] [Related]
4. Pre-clinical evidence of enhanced oral bioavailability of the P-glycoprotein substrate talinolol in combination with morin.
Pathak SM; Udupa N
Biopharm Drug Dispos; 2010 Mar; 31(2-3):202-14. PubMed ID: 20238375
[TBL] [Abstract][Full Text] [Related]
5. Enhanced oral bioavailability of morin administered in mixed micelle formulation with PluronicF127 and Tween80 in rats.
Choi YA; Yoon YH; Choi K; Kwon M; Goo SH; Cha JS; Choi MK; Lee HS; Song IS
Biol Pharm Bull; 2015; 38(2):208-17. PubMed ID: 25747979
[TBL] [Abstract][Full Text] [Related]
6. pH-dependent functional activity of P-glycoprotein in limiting intestinal absorption of protic drugs: kinetic analysis of quinidine efflux in situ.
Varma MV; Panchagnula R
J Pharm Sci; 2005 Dec; 94(12):2632-43. PubMed ID: 16258992
[TBL] [Abstract][Full Text] [Related]
7. Capsaicin pretreatment enhanced the bioavailability of fexofenadine in rats by P-glycoprotein modulation: in vitro, in situ and in vivo evaluation.
Bedada SK; Appani R; Boga PK
Drug Dev Ind Pharm; 2017 Jun; 43(6):932-938. PubMed ID: 28102715
[TBL] [Abstract][Full Text] [Related]
8. Prediction of in vivo intestinal absorption enhancement on P-glycoprotein inhibition, from rat in situ permeability.
Varma MV; Panchagnula R
J Pharm Sci; 2005 Aug; 94(8):1694-704. PubMed ID: 15986467
[TBL] [Abstract][Full Text] [Related]
9. Circadian variations in exsorptive transport: in situ intestinal perfusion data and in vivo relevance.
Okyar A; Dressler C; Hanafy A; Baktir G; Lemmer B; Spahn-Langguth H
Chronobiol Int; 2012 May; 29(4):443-53. PubMed ID: 22489638
[TBL] [Abstract][Full Text] [Related]
10. Multiple efflux pumps are involved in the transepithelial transport of colchicine: combined effect of p-glycoprotein and multidrug resistance-associated protein 2 leads to decreased intestinal absorption throughout the entire small intestine.
Dahan A; Sabit H; Amidon GL
Drug Metab Dispos; 2009 Oct; 37(10):2028-36. PubMed ID: 19589874
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of enhanced oral absorption of morin by phospholipid complex based self-nanoemulsifying drug delivery system.
Zhang J; Li J; Ju Y; Fu Y; Gong T; Zhang Z
Mol Pharm; 2015 Feb; 12(2):504-13. PubMed ID: 25536306
[TBL] [Abstract][Full Text] [Related]
12. P-glycoprotein is responsible for the poor intestinal absorption and low toxicity of oral aconitine: in vitro, in situ, in vivo and in silico studies.
Yang C; Zhang T; Li Z; Xu L; Liu F; Ruan J; Liu K; Zhang Z
Toxicol Appl Pharmacol; 2013 Dec; 273(3):561-8. PubMed ID: 24120885
[TBL] [Abstract][Full Text] [Related]
13. In situ and in vivo efficacy of peroral absorption enhancers in rats and correlation to in vitro mechanistic studies.
Sharma P; Varma MV; Chawla HP; Panchagnula R
Farmaco; 2005; 60(11-12):874-83. PubMed ID: 16243320
[TBL] [Abstract][Full Text] [Related]
14. In Vitro and In Vivo Evaluation of Olmesartan Medoxomil Microcrysta ls and Nanocrystals: Preparation, Characterization, and Pharmacokinet ic Comparison in Beagle Dogs.
Chai R; Gao H; Ma Z; Guo M; Fu Q; Liu H; He Z
Curr Drug Deliv; 2019; 16(6):500-510. PubMed ID: 31244438
[TBL] [Abstract][Full Text] [Related]
15. Effect of binary and ternary solid dispersions on the in vitro dissolution and in-situ rabbit intestinal absorption of gliclazide.
El-Maghraby GM; Alomrani AH
Pak J Pharm Sci; 2011 Oct; 24(4):459-68. PubMed ID: 21959805
[TBL] [Abstract][Full Text] [Related]
16. Curcumin-loaded solid lipid nanoparticles with Brij78 and TPGS improved in vivo oral bioavailability and in situ intestinal absorption of curcumin.
Ji H; Tang J; Li M; Ren J; Zheng N; Wu L
Drug Deliv; 2016; 23(2):459-70. PubMed ID: 24892628
[TBL] [Abstract][Full Text] [Related]
17. Solid lipid nanoparticles as vesicles for oral delivery of olmesartan medoxomil: formulation, optimization and in vivo evaluation.
Nooli M; Chella N; Kulhari H; Shastri NR; Sistla R
Drug Dev Ind Pharm; 2017 Apr; 43(4):611-617. PubMed ID: 28005442
[TBL] [Abstract][Full Text] [Related]
18. Concentration- and region-dependent intestinal permeability of fluvastatin in the rat.
Lindahl A; Sandström R; Ungell AL; Lennernäs H
J Pharm Pharmacol; 1998 Jul; 50(7):737-44. PubMed ID: 9720622
[TBL] [Abstract][Full Text] [Related]
19. [The inhibitory effect of pluronic on P-glycoprotein drug pump].
Huang JG; Si LQ; Zuo KY; Wu XG; Qiu J; Li G
Yao Xue Xue Bao; 2007 Sep; 42(9):989-94. PubMed ID: 18050744
[TBL] [Abstract][Full Text] [Related]
20. Conversion of Olmesartan to Olmesartan Medoxomil, A Prodrug that Improves Intestinal Absorption, Confers Substrate Recognition by OATP2B1.
Fukazawa N; Nishimura T; Orii K; Noguchi S; Tomi M
Pharm Res; 2024 May; 41(5):849-861. PubMed ID: 38485855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
